dose-related 中文意思是什麼

dose-related 解釋
劑量相關
  • dose : n 1 (藥的)一服,一劑;藥量,劑量。2 苦藥,討厭的東西。3 (酒中的)配料,增味劑。4 (處罰等)一...
  • related : adj. 1. 所敘述的,所說的。2. 相關的,有關系的〈尤指有親戚關系的〉。3. 【音樂】和聲的。n. -ness
  1. The decline in viability of the algae is exponential and can not be related to a linear dose effect.

    小球藻生活力的降低是指數性質的,而與線性劑量效應無關。
  2. However, a necrotizing steroid myopathy has also been reported to occur. proximal muscle weakness of the lower and upper extremities is significantly related to the cumulative dose of steroid

    但是,壞死性的類固醇肌病也有報道。上肢和下肢近端肌無力與類固醇累積劑量有關。
  3. 2 bristow mr, gilbert em, abraham wt, et al. carvedilol produces dose - related improvements in left ventricular function and survival in subjects with chronic heart failure. circulation. 1996, 94 : 2807

    4孫安盛,張煒,劉國雄.異鉤藤堿對麻醉兔心臟傳導功能的影響.中國藥理學與毒理學雜志, 1995 , 9 : 113
  4. 3. calcitonin gene - related peptide attenuates glutamate - induced inhibition of pulmonary surfactant lipid synthesis ( d cgrp could reverse the decrease of [ 3h ] - choline incorporation induced by glu with dose - dependence ; ( 2 ) cgrp could block the decrease of the content of cct a mrna induced by glu in lung tissue ; ( 3 } cgrp could reduce the impairment of the ultrastructure of at ii cells induced by glu ; ( 4 ) cgrp could reverse the increase of mda content and decrease of sod level induced by glu in cultured lung explants, respectively ; ? grp had no significant effect on nos activity and increase of no production induced by glu

    降鈣素基因相關肽減輕谷氨酸所致肺表面活性物質脂質合成抑制的保護作用降鈣素基因相關肽grp )可顯著減輕0所致肺組織h一膽堿摻入pc量的降低,並且呈劑量依賴保護效應; cgrp可逆轉gill所致cctqinrna含量的降低; cgrp可減輕o所致肺11上皮細胞超微結構的損傷; cgrp可逆轉o所致肺組織勻漿中mda含量增多、 sod水平降低的效應,並可逆轉q所致肺組織ldh釋放增多的效應; cg販對gill引起的nos活性和no含量的升高均沒有顯著性影響。
  5. These results suggest that the transcriptional factor is the p50 - p65 heterodimer of nf - b. conclusion : 1. the expression of mbd3 gene can be induced in liver during the systemic acute - phase response to the challenge by lps ; 2. the acute phase - related mbd3 gene expression appears to be time - and dose - dependant of lps stimulation ; 3

    結論: 1 . lps刺激引起小鼠急性時相反應可誘導mbd3基因在肝臟中表達; 2 . lps誘導的mbd3基因的急性時相表達具有劑量和時間依賴性; 3 . nf一『 b活化后參與mbd3基因誘導表達的轉錄調節。
  6. This paper makes use of the trained bp network to identify the dose of gun - powder product and related interpolation algorithms are used, and the better identification

    論文利用訓練好的bp神經網路模型系統對火炸藥產品的藥劑量進行了辨識,並進行相關的插值平滑,得到了較好的辨識結果。
  7. Such symptoms appear to be dose - related, with an incidence of between 1 % and 4 % at usual therapeutic doses

    這些癥狀的出現與劑量相關。在常用的治療劑量時,發生率為1 % 4 % 。
  8. In order to further investigate the role of axudl in human tumor carcinogenesis and the potential association between the axudl gene expression status and the stimulation of transforming growth factor beta in human cancers, the present study was performed in three aspects as follows : ( 1 ) cloning full length enconding region cdna of axudl and construction of eukaryotic vector that expression the fusion protein of axud1 and influenza virus hemagglutin ha epitope tag ; ( 2 ) exploring the time and dose effects of tgf - 1 on the expression - of axudl gene in hepg2 hepatoma cells and spc - a1 lung carcinomas cells, and studying the effects of overexpression of axud1 on the expression of cell cycle and apoptosis related protein in hepg2 hepatoma cells ; ( 3 ) construction and expression of human axudl in e. coli m15. the following main results and conclusions can be obtained from the present study : 1. the full length ecnoding region of human axudl cdna from human peripheral blood lymphocytes was successfully cloned using one step rt - pcr method, and constructed into a eukaryotic expression vector which can be expressed a ha - axud1 fusion protein with axud1 and influenza virus hemagglutin ha epitope tag. the recombinant plasmid was identified by polymerase chain reaction, restriction endonuclease maping and sequencing, this expression vector might be instrumental to further study the function of axud1 protein in tumor cells

    為了進一步研究axud1在人類腫瘤發生中的作用及axud1基因的表達狀況與tgf -介導的信號通路的關系,本實驗研究分為三個部分: ( 1 ) axud1基因cdna全長編碼區的克隆和ha表位標記的axud1基因表達載體的構建; ( 2 )探討肝癌細胞hepg2和肺腺癌spc - a1細胞中tgf - 1誘導的axud1基因表達的時間、劑量效應以及誘導表達的可能機理,並研究axud1的過表達對細胞周期和細胞凋亡相關蛋白表達的影響; ( 3 ) axud1原核表達載體的構建及其在大腸桿菌中的表達。本實驗的主要結果和結論如下: 1利用一步法rt - pcr成功地從人類外周血淋巴細胞中克隆出axud1基因編碼區cdna ,並將其構建入真核表達載體中,編碼的ha - axud1融合蛋白帶有流感病毒凝血素ha的表位標記肽段。
  9. The results of statistics showed that maternal age of ds had a tendency to decrease. the results of maternal exposed factors multi - unconditional logistic model showed that long time and low dose radiation and smoked were significantly related with ds

    最後將結果用spss10 . 0進行統計分析,對ds父母親的環境因子暴露情況進行了單因素的基本分析和多因素非條件logistic回歸分析。
  10. This paper introduces radiation dose control for mainly tech - modifications items related to radiation, including radiation protection optimization measures and experience in aspects of item planning, program writing, process control, etc

    本文簡要介紹了與輻射相關的主要技術改造項目中的輻射劑量控制,包括項目計劃、方案制定、過程式控制制等方面的輻射防護最優化措施和經驗。
  11. There were no drug - attributed serious adverse events, and no pattern of dose - related or treatment - related clinical side effects or laboratory abnormalities

    沒有因藥物嚴重副作用,沒有與劑量相關或治療相關的臨床副作用或實驗室指標異常。
  12. Methods : australian and new zealand patients who received low - dose hbig plus lamivudine following liver transplantation for hbv - related end - stage liver disease were studied

    方法:選擇澳洲和紐西蘭曾接受乙型肝炎免疫球蛋白聯合拉米夫定的患者,對這類患者行肝移植后發生的與乙型肝炎病毒相關的末期肝臟疾病進行研究。
  13. Only il - 1 could be used to predispose mesencephalic neural progenitors to enrich cell yield in a neuronal phenotype before cell transplantation. ( 2 ) the effects of cntf and il - 1 on neural progenitor differentiation were dose - related. ( 3 ) coeffects of elf - emf and cytokines were neither synergized nor antagonized, implying a potential role of organism emf during cns development

    顯示emf與cntf 、 il一1a的共同效應不是簡單的脅同或拮抗,提示emf可能與細胞因子共同影u向應著神經系統的發育。
  14. Generally, we recommend that metabolites identified in human plasma that account for greater than 10 percent of drug related material ( administered dose or systemic exposure whicheer is less ) be considered for safety assessment

    我們推薦:一般來說,如果人血漿中檢測到的藥物代謝產物濃度超過藥物相關物質的10 % (無論是藥物給予量還是全身接觸因素) ,就需要考慮安全性評估
分享友人